3-Bromo-5-meth-oxy-4-(4-methyl-piperidin-1-yl)furan-2(5H)-one
- PMID: 21754143
- PMCID: PMC3099783
- DOI: 10.1107/S1600536811008804
3-Bromo-5-meth-oxy-4-(4-methyl-piperidin-1-yl)furan-2(5H)-one
Abstract
There are two molecules in the asymmetric unit of title compound, C(11)H(16)BrNO(3), which was obtained via the tandem Michael addition-elimination reaction of 3,4-dibromo-5-meth-oxy-furan-2(5H)-one and 4-methyl-piperidine in the presence of potassium fluoride. The furan-one rings are approximately planar [maximum atomic deviations of 0.026 (2) and 0.015 (2) Å, respectively]. The packing is stabilized by weak inter-molecular C-H⋯O and C-H⋯Br inter-actions.
Figures
References
-
- Bruker (2008). APEX2 and SAINT Bruker AXS Inc., Madison, Wisconsin, USA.
-
- Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
-
- Lattmann, E., Billington, D. C. & Langley, C. A. (1999). Drug Des. Discov 16, 243–250. - PubMed
-
- Lattmann, E., Dunn, S., Niamsanit, S. & Sattayasai, N. (2005). Bioorg. Med. Chem. Lett. 15, 919–921. - PubMed
-
- Lattmann, E., Sattayasai, N., Schwalbe, C. S., Niamsanit, S., Billington, D. C., Lattmann, P., Langley, C. A., Singh, H. & Dunn, S. (2006). Curr. Drug Discov. Technol. 3, 125–134. - PubMed
LinkOut - more resources
Full Text Sources